Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of venous thrombosis in cancer patients with enoxaparin
2005-002068-27Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of enoxaparin in cancer (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Hemostatic activation markers. Started Mar 2006; status: completed.
02
Drugs
enoxaparin
03
Conditions
cancer
Beyond the preview
Go deeper on 2005-002068-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002068-27.